HIGHLIGHTS
- who: November and collaborators from the of Chinese Medical Sciences, China The University of Hong Kong, Hong have published the research: Ef cacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials, in the Journal: (JOURNAL)
- what: The assessment of ROB includes the following five domains: 1) bias arising from the randomization process; 2) bias due to deviations from intended interventions; 3) bias due to frontiersin.org 10.3389/fphar.2022.1002713 12 studies were not RCTs, two studies were inconsistent interventions . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.